SCHEMBL3370457

SCHEMBL3370457

[CH]1CCCN1N1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6838748 0.97
SCHEMBL2011389 0.92
SCHEMBL7238131 0.82
SCHEMBL7734499 0.81
SCHEMBL5526974 0.78 POLB (0.31)
SCHEMBL10395834 0.72
SCHEMBL30601598 0.70
SCHEMBL3734701 0.67
SCHEMBL9818279 0.65
SCHEMBL16717421 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103221397-A Novel compositions and methods for controlling nematode pests MONSANTO TECHNOLOGY LLC 2013-07-24 CN claimed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN disclosed
CN-113004278-B Bicyclic heterocycles as FGFR inhibitors 因赛特控股公司 2023-07-21 CN disclosed
US-20230175005-A1 PLANTS HAVING INCREASED TOLERANCE TO HERBICIDES BASF SE (DE) 2023-06-08 US disclosed
US-20230157289-A1 HERBICIDAL PHENYLURACILS BASF SE (DE) 2023-05-25 US disclosed
WO-2023031161-A1 PLANTS HAVING INCREASED TOLERANCE TO HERBICIDES BASF Agricultural Solutions Seed US LLC (US) 2023-03-09 WO disclosed
WO-2023030936-A1 URACIL MOIETY CONTAINING THIOETHER COMPOUNDS FOR USE AS HERBICIDES BASF SE (DE) 2023-03-09 WO disclosed
EP-4114828-A1 HERBICIDAL PHENYLURACILS BASF SE (DE) 2023-01-11 EP disclosed
EP-3464261-B1 HERBICIDAL URACILPYRID BASF SE (DE) 2021-07-07 EP disclosed
US-20210155618-A1 SPIROHEPTANYL HYDANTOINS AS ROCK INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2021-05-27 US disclosed
US-20070015743-A1 Quinazoline derivatives as antitumor agents ASTRAZENECA AB (SE) 2007-01-18 US disclosed
EP-1713781-A1 QUINAZOLINE DERIVATIVES AstraZeneca AB (SE) 2006-10-25 EP disclosed
EP-1667996-A1 QUINAZOLINE DERIVATIVES Astrazeneca AB (SE) 2006-06-14 EP disclosed
EP-1664029-A1 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS AstraZeneca AB (SE) 2006-06-07 EP disclosed
EP-1664028-A1 QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS AstraZeneca AB (SE) 2006-06-07 EP disclosed
WO-2005075439-A1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2005-08-18 WO disclosed
WO-2005026151-A1 QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS ASTRAZENECA AB (SE) 2005-03-24 WO disclosed
WO-2005026152-A1 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2005-03-24 WO disclosed
WO-2005026157-A1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2005-03-24 WO disclosed
US-20050009706-A1 Alpha-cyanoacrylates BASF SE (DE) 2005-01-13 US disclosed